Sign in with Google
bullish
Classys (214150 KS): Beautiful Journey Continues; Record High Revenue and Operating Profit in 1Q24
377 Views09 May 2024 07:35
SUMMARY
- Classys (214150 KS) started 2024 on a strong note with highest ever quarterly revenue and operating profit in 1Q24. Faster-than-expected consumables orders from overseas markets drove the overall performance.
- The proportion of consumable sales rose to 53% (1Q23: 48% and 4Q23: 43%), increasing by 42% and 32% QoQ. Increasing contribution from high-margin consumables sales improved the profitability substantially.
- Favorable industry tailwind, global expansion, and new launches remain main growth drivers. Classys still expects 2024 revenue of KRW225B, up 25% YoY. In April, Classys obtained FDA approval for Volnewmer.
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- CATL H Share Listing: AH Discount Views
- Aged Care Sector - Montgomerie-Ibbotson Aged Care Pricing Index
- Singapore: Lawrence Wong Boosted by Mild Improvement in PAP Vote Share
- ASX200 (AS51 INDEX) Outlook: Rallying Out of a Bear Market Amid Passive Flows And Sector Strength
- Last Week in Event SPACE: Toyota, Rio Tinto, Hainan Meilan, Fujitsu General
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ABL Bio Capital Raise of 140 Billion Won02 Jul 2024
- Arb Spread Has Opened Today in Classys & Ilooda Merger Swap: Checking Trade Feasibility27 Jun 2024
- Merger Between Classys and Ilooda Likely to Reduce Local Competition26 Jun 2024
- Classys: One of Korea's Top Beauty Medical Device Makers + Higher Shares Cancellation and Dividends08 Mar 2024
- Classys (214150 KS): 2023 Sales Beat Guidance to Reach Record High; Stellar Performance to Continue01 Mar 2024
- Classys (214150 KS): Record High Quarterly Performance in Q3; 2024 to Continue to Be Radiant25 Nov 2023
x